EP 2207669 A1 20100721 - BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS
Title (en)
BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS
Title (de)
BAKTERIOSTATISCHE ODER BAKTERIOZIDE ZUSAMMENSETZUNGEN UND VERFAHREN
Title (fr)
COMPOSITIONS BACTÉRIOSTATIQUES OU BACTÉRIOCIDES ET PROCÉDÉS
Publication
Application
Priority
- US 2008081029 W 20081023
- US 98272007 P 20071025
- US 98271907 P 20071025
- US 2007082578 W 20071025
- US 2007082580 W 20071025
- US 2007082581 W 20071025
- US 4841608 P 20080428
- US 4833208 P 20080428
- US 4840408 P 20080428
- US 4834008 P 20080428
- US 4834708 P 20080428
Abstract (en)
[origin: WO2009055620A1] Particular aspects provide compositions and methods for treating or preventing bacterial infection or at least one symptom related to bacterial infection, and the like in a subject in need thereof by administering a therapeutic composition comprising at least one electrokinetically generated fluid (including gas-enriched electrokinetically generated fluids) as disclosed herein, the electrokinetically altered aqueous fluid suitable to alter cellular membrane structure or function sufficient to provide for modulation of intracellular signal transduction, wherein treating bacterial infection or at least one symptom related to bacterial infection is thereby afforded. In particular embodiments, the fluids are gas-enriched fluids or therapeutic compositions and methods, and include oxygen-enriched water optionally in combination with other therapeutic agents. Other embodiments include particular routes of administration or formulations for the gas-enriched therapeutic compositions.
IPC 8 full level
A61K 33/00 (2006.01); C12N 5/00 (2006.01); C12N 13/00 (2006.01); G01N 33/68 (2006.01)
CPC (source: EP)
A61K 33/00 (2013.01); A61K 45/06 (2013.01); A61P 11/00 (2017.12); A61P 11/02 (2017.12); A61P 11/06 (2017.12); A61P 11/08 (2017.12); A61P 11/14 (2017.12); A61P 31/04 (2017.12); A61P 31/16 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C12N 13/00 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2009055620 A1 20090430; AU 2008316556 A1 20090430; AU 2008316556 B2 20141218; AU 2008316708 A1 20090430; CA 2703648 A1 20090430; CA 2703714 A1 20090430; CN 101909649 A 20101208; CN 101909649 B 20140129; CN 101909869 A 20101208; CN 101909869 B 20141217; CN 103721258 A 20140416; CN 103721258 B 20151209; EP 2207669 A1 20100721; EP 2207669 A4 20111102; EP 2214712 A1 20100811; EP 2214712 A4 20130227; EP 2214712 B1 20160518; IL 205320 A0 20101230; IL 205320 A 20170330; IL 205321 A0 20101230; JP 2011500838 A 20110106; JP 2011500854 A 20110106; JP 2015028087 A 20150212; JP 5586470 B2 20140910; JP 5647897 B2 20150107; JP 5750540 B2 20150722; MX 2010004549 A 20100728
DOCDB simple family (application)
US 2008081029 W 20081023; AU 2008316556 A 20081027; AU 2008316708 A 20081023; CA 2703648 A 20081023; CA 2703714 A 20081027; CN 200880122809 A 20081027; CN 200880122810 A 20081023; CN 201310717654 A 20081027; EP 08841984 A 20081027; EP 08842668 A 20081023; IL 20532010 A 20100425; IL 20532110 A 20100425; JP 2010531258 A 20081023; JP 2010531321 A 20081027; JP 2014228037 A 20141110; MX 2010004549 A 20081023